Skip to main content

Treatment cost tracking

Know what each treatment really costs.

Treatment pricing only tells part of the story. Product usage, consumables, stock waste and supplier cost all affect what the clinic actually earns from each treatment.

Back to Stock & Products
Why product cost matters to treatment profitability

The real cost of a treatment is more than the price charged.

These four areas show why linking product usage to treatment cost gives the clinic a clearer picture of what each appointment actually delivers.

Product cost is part of treatment cost

A treatment may look profitable until product usage is properly counted. Injectables, consumables, dressings and other supplies all affect the true cost.

Usage linked to the appointment

Treatment cost tracking works better when products used are linked to the actual treatment, not estimated later from memory or stock counts.

Spot margin pressure

Clinics can see where product usage, supplier cost or wastage may be affecting treatment profitability.

Support better pricing decisions

Clearer cost data helps the clinic review pricing, treatment packages and product choices with more confidence.

How treatment cost tracking works in practice

Three steps from product usage to cost visibility.

Stock is not just an operational issue. It affects cash flow, margins and treatment profitability.

  1. Confirm products used in the room
    Products, quantities and batches are confirmed as part of the treatment workflow, giving the clinic accurate usage data before the appointment is closed.
  2. Review product cost against the treatment
    Confirmed usage links to product cost, so the clinic can see what the appointment cost to deliver rather than estimating from average figures.
  3. See treatment profitability more clearly
    When treatment cost is built from actual usage rather than rough estimates, the clinic has a more reliable basis for pricing, planning and product decisions.

See the real product cost behind each treatment.

Product usage, consumables and supplier costs connected to treatment-level costing.